# ClinicalTrials.gov record NCT02717858

> PeptideScanner retained ClinicalTrials.gov record NCT02717858 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-06-28, and PeptideScanner's reviewed identity mapping was liraglutide.

- Evidence object: `story:clinicaltrials-gov-nct02717858-liraglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-06-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02717858-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02717858-liraglutide-v1.json
- Content SHA-256: `475488550e1214f8296cc2d972aecf56a1721967cb5a2d45716c0c777bc3a88b`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02717858 ([`ctg-observation-nct02717858-2018-06-28-0e48f4fef8fd`](#source-ctg-observation-nct02717858-2018-06-28-0e48f4fef8fd))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02717858 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-06-28, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct02717858-2018-06-28-0e48f4fef8fd`](#source-ctg-observation-nct02717858-2018-06-28-0e48f4fef8fd))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02717858 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-06-28, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct02717858-2018-06-28-0e48f4fef8fd`](#source-ctg-observation-nct02717858-2018-06-28-0e48f4fef8fd))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02717858-2018-06-28-0e48f4fef8fd`](#source-ctg-observation-nct02717858-2018-06-28-0e48f4fef8fd))

## Sources

<a id="source-ctg-observation-nct02717858-2018-06-28-0e48f4fef8fd"></a>
- **ClinicalTrials.gov record NCT02717858 · retained source version 2018-06-28:0e48f4fef8fd8e9127f10e5de37fece0a62d0a57f71f9663f844db8c0acf2fbc** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02717858) (`ctg-observation-nct02717858-2018-06-28-0e48f4fef8fd`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02717858." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02717858-liraglutide-v1.json SHA-256: 475488550e1214f8296cc2d972aecf56a1721967cb5a2d45716c0c777bc3a88b.